Clinical Guidelines

The 60 Percent Diagnostic Gap in M/E

What earlier mNGS testing could mean for labs and clinicians

Share

Meningitis and encephalitis (M/E) diagnostics often lead to undetermined causes despite extensive testing. Steve Miller from Delve Bio discusses a study that explores earlier use of metagenomic next-generation sequencing (mNGS) to enhance M/E diagnostics. Traditional hypothesis-driven methods can leave over 60% of cases undiagnosed due to limited testing, while mNGS can reduce the need for microbiologic tests and shorten diagnosis time significantly. This could ultimately affect treatment decisions and hospital stays.

Original Source(s)

The 60 Percent Diagnostic Gap in M/E

  • by Jessica Allerton

  • March 12, 2026

Related Content

RSV Vaccine Eligibility Expands

Trial data show noninferior immune response in high-risk adults aged 18 to 49 years.

Clinicians Warn of Fatal Measles Brain Disease

Doctors caution that measles infection can lead to SSPE, a rare fatal neurologic disease that may appear years later.

The New Blueprint for Vaccine Development

ReiThera’s leaders discuss platform technologies, scalable manufacturing, and the trust needed to strengthen global vaccine preparedness

  • March 12, 2026

  • 6 min